Skip to main content

Table 1 Patient, pharmacy and community level characteristics on MCA-eligible pharmacy claim-dates

From: Factors affecting the delivery of community pharmacist-led medication reviews: evidence from the MedsCheck annual service in Ontario

Characteristics

MCA claims

n = 65,605

Non-MCA claims

n = 2,787,387

P-value

Patient-level characteristics defined at the first claim-date

 Age (years), n (%)

  66–70

16,717 (25.5)

674,825 (24.2)

*

  71–75

16,444 (25.1)

617,611 (22.2)

  76–80

14,754 (22.5)

572,702 (20.6)

  81–85

10,741 (16.4)

474,862 (17.0)

  86+

6,949 (10.6)

447,387 (16.0)

Female, n (%)

36,471 (55.6)

1,632,655 (58.6)

*

Recent immigrant (<15 years), n (%)

2,086 (3.2)

65,645 (2.4)

*

Hypertension, n (%)

55,035 (83.9)

2,286,761 (82.0)

*

Ischemic heart disease, n (%)

12,111 (18.5)

534,862 (19.2)

*

Heart failure, n (%)

7,281 (11.1)

445,334 (16.0)

*

Diabetes, n (%)

17,252 (26.3)

1,054,580 (37.8)

*

COPD/asthma, n (%)

20,650 (31.5)

980,904 (35.2)

*

Osteoporosis, n (%)

12,875 (19.6)

545,372 (19.6)

0.709

Cancer, n (%)

11,876 (18.1)

500,281 (17.9)

0.311

Depression, n (%)

1,857 (2.8)

110,137 (4.0)

*

Dementia, n (%)

2,388 (3.6)

216,747 (7.8)

*

Prior MCA, n (%)

37,820 (57.6)

944,962 (33.9)

*

 Adherent to ACEi/ARB/statin, n (%)

  No

4,388 (6.7)

164,301 (5.9)

*a

  Yes

45,390 (69.2)

1,907,223 (68.4)

  NA (not receiving)

15,827 (24.1)

715,863 (25.7)

Number of ADGs in past 2 years, mean (SD)

8.1 (3.7)

8.4 (3.9)

*

Number of ED admissions in the last year, mean (SD)

0.6 (1.4)

0.829 (1.8)

*

Number of hospitalizations in the last year, mean (SD)

0.5 (0.9)

0.542 (1.1)

*

Number of physicians in the last year, mean (SD)

7.9 (6.7)

8.6 (7.8)

*

Patient-level characteristics defined at each claim-date

New hospitalization/ED admission in past 60 days, n (%)

9,921 (15.1)

457,454 (16.4)

*

Use of high risk medication in past 6 months, n (%)

52,928 (80.7)

2,314,441 (83.0)

*

Use of PIMs in past 6 months, n (%)

27,532 (42.0)

1,406,024 (50.4)

*

New prescription medication at claim-date, n (%)

16,026 (24.4)

396,030 (14.2)

*

Number of physicians in past 3 months, mean (SD)

5.2 (5.0)

5.3 (5.4)

*

Number of unique medications in past 4 months, mean (SD)

6.7 (3.5)

7.8 (4.3)

*

 Number of unique medications in past 4 months (quintiles), n (%)

  0–4

19,232 (29.3)

668635 (24.0)

*

  5–6

17,672 (26.9)

553817 (19.9)

  7–8

12,529 (19.1)

507791 (18.2)

  9–11

10,111 (15.4)

544720 (19.5)

  12–42

6,061 (9.2)

512424 (18.4)

Pharmacy-level characteristic

 Pharmacy volume (quintiles), n (%)

  1 (lowest)

4,940 (7.8)

137,937 (5.1)

*

  2

9,147 (14.5)

283,112 (10.5)

  3

13,661 (21.6)

461,396 (17.2)

  4

16,757 (26.5)

675,308 (25.1)

  5 (highest)

18,726 (29.6)

1,129,756 (42.0)

Community-level characteristics

 Rurality index of Ontario, n (%)

  0–9 (major urban)

47,470 (72.8)

1,744,607 (63.2)

*

  10–44 (non-major urban)

14,210 (21.8)

803,936 (29.1)

  45+ (rural)

3,559 (5.5)

211,667 (7.7)

 Income quintiles, n (%)

  1 (lowest)

11,582 (17.7)

569,300 (20.5)

*

  2

13,593 (20.8)

583,981 (21.0)

  3

12,999 (19.9)

546,306 (19.7)

  4

13,397 (20.5)

542,397 (19.5)

  5 (highest)

13,825 (21.1)

533,984 (19.2)

 Material deprivation quintiles, n (%)

  1 (lowest)

16,114 (24.8)

602,791 (22.0)

*

  2

15,327 (23.6)

610,747 (22.3)

  3

13,919 (21.4)

591,068 (21.5)

  4

11,192 (17.2)

515,031 (18.8)

  5 (highest)

8,365 (12.9)

424,022 (15.5)

  1. *P-value < 0.001. a‘No’ versus ‘Yes’
  2. ACEi indicates angiotensin converting enzyme inhibitor; ADG Aggregated Diagnosis Group based on the Johns Hopkins Ambulatory Care Group case-mix system, ARB angiotensin receptor blocker, COPD chronic obstructive pulmonary disease, ED emergency department, MCA MedsCheck Annual, NA not applicable, PIM Potentially inappropriate medication, SD standard deviation